These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 11330099)

  • 1. Bond sales surge still in forecast.
    Jaklevic MC
    Mod Healthc; 2001 Apr; 31(16):36, 39. PubMed ID: 11330099
    [No Abstract]   [Full Text] [Related]  

  • 2. Bond sales pick up in second quarter.
    Jaklevic MC
    Mod Healthc; 2000 Jul; 30(30):36. PubMed ID: 11184171
    [No Abstract]   [Full Text] [Related]  

  • 3. Volume set on high. Tax-exempt bond sales climb 25% in the second quarter.
    Pallarito K
    Mod Healthc; 1997 Jul; 27(28):88, 90. PubMed ID: 10168526
    [No Abstract]   [Full Text] [Related]  

  • 4. 1998 bond sales shatter record.
    Pallarito K
    Mod Healthc; 1999 Jan; 29(3):37, 39. PubMed ID: 10345452
    [No Abstract]   [Full Text] [Related]  

  • 5. Bidding for business. Bond sales getting more competitive; on-line auctions among the options.
    Pallarito K
    Mod Healthc; 1998 Aug; 28(33):37. PubMed ID: 10183086
    [No Abstract]   [Full Text] [Related]  

  • 6. Loading up on debt. Bond issuances on track to break $29 billion record.
    Pallarito K
    Mod Healthc; 1998 Oct; 28(42):44. PubMed ID: 10186327
    [No Abstract]   [Full Text] [Related]  

  • 7. Capital spigot dripping faster.
    Jaklevic MC
    Mod Healthc; 2002 Feb; 32(5):35-6. PubMed ID: 11859821
    [No Abstract]   [Full Text] [Related]  

  • 8. Growing by leaps and bonds. Not-for-profits sell more despite weak ratings.
    Jaklevic MC
    Mod Healthc; 2004 Jan; 34(2):8-9. PubMed ID: 14959626
    [No Abstract]   [Full Text] [Related]  

  • 9. Bonds rebounding after a slow start.
    Jaklevic MC
    Mod Healthc; 2000 May; 30(18):88, 90. PubMed ID: 11067145
    [No Abstract]   [Full Text] [Related]  

  • 10. Bond sales steady in third quarter.
    Jaklevic MC
    Mod Healthc; 2000 Oct; 30(42):40. PubMed ID: 11142205
    [No Abstract]   [Full Text] [Related]  

  • 11. Pricier, less plentiful. For many providers, gone are the days of free-flowing capital.
    Jaklevic MC
    Mod Healthc; 2000 May; 30(21):52-4, 56. PubMed ID: 11067550
    [No Abstract]   [Full Text] [Related]  

  • 12. Bond sales slump 39% in first half.
    Pallarito K
    Mod Healthc; 1995 Jul; 25(29):44-5. PubMed ID: 10144055
    [No Abstract]   [Full Text] [Related]  

  • 13. Rising rates sink bond sales in 2000.
    Jaklevic MC
    Mod Healthc; 2001 Jan; 31(3):50, 52. PubMed ID: 11418950
    [No Abstract]   [Full Text] [Related]  

  • 14. Cranking up the volume. Healthcare bond sales hit highest level in three years.
    Pallarito K
    Mod Healthc; 1997 Jan; 27(2):50-1. PubMed ID: 10164346
    [No Abstract]   [Full Text] [Related]  

  • 15. A voluminous year. Low interest rates likely to fuel bond sales momentum.
    Pallarito K
    Mod Healthc; 1998 Jan; 28(3):40. PubMed ID: 10175935
    [No Abstract]   [Full Text] [Related]  

  • 16. Bond volume slows from 1998 record.
    Jaklevic MC
    Mod Healthc; 2000 Jan; 30(4):38. PubMed ID: 11009991
    [No Abstract]   [Full Text] [Related]  

  • 17. Bond market ends '95 on high note.
    Pallarito K
    Mod Healthc; 1996 Jan; 26(3):35-6. PubMed ID: 10153984
    [No Abstract]   [Full Text] [Related]  

  • 18. Healthy market for tax-exempt bonds.
    Jaklevic MC
    Mod Healthc; 2001 Oct; 31(42):30, 32. PubMed ID: 11682898
    [No Abstract]   [Full Text] [Related]  

  • 19. The price of secrecy. Failure to be forthcoming with financial data could prove costly for bond issuers.
    Pallarito K
    Mod Healthc; 1998 Dec; 28(50):37, 41. PubMed ID: 10187721
    [No Abstract]   [Full Text] [Related]  

  • 20. Closing in on a record. Healthcare bond volume remains robust in third quarter.
    Pallarito K
    Mod Healthc; 1997 Oct; 27(41):66-7. PubMed ID: 10173652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.